If Amyloid Fails, We Are 15 Years Away from Having a Treatment Industry is in the business of developing products. For Alzheimer’s disease this has… Read more
Nsight Barbara Nelsen on the business of science.
Catching up on Minnesota news in the Star Tribune a few weeks ago, the following headline caught my eye: “Minnesota loses when tech firms head… Read more
On November 20th I hosted a panel of experts representing medical devices, diagnostics, research tools, and biopharma at Minnesota’s LifeScience Alley’s 2013 annual conference. The… Read more